Eskil Elmér

About

Eskil Elmér is a Swedish physician-scientist and biotech founder best known for founding NeuroVive Pharmaceutical, later renamed Abliva, a mitochondrial-disease drug developer based in Lund. He served as the company’s long-time Chief Scientific Officer and earlier CEO/board member, while also maintaining academic and clinical ties to Lund University and neurophysiology. Public sources position him primarily as a scientific and company-building figure in mitochondrial medicine rather than as a fund manager or documented capital allocator.

Areas of interest